Skip to main content
Top
Published in: BMC Infectious Diseases 1/2009

Open Access 01-12-2009 | Research article

The epidemiology of pertussis in Germany: past and present

Authors: Wiebke Hellenbrand, Dietmar Beier, Evelin Jensen, Martina Littmann, Christiane Meyer, Hanna Oppermann, Carl-Heinz Wirsing von König, Sabine Reiter

Published in: BMC Infectious Diseases | Issue 1/2009

Login to get access

Abstract

Background

Current and past pertussis epidemiology in the two parts of Germany is compared in the context of different histories of vaccination recommendations and coverage to better understand patterns of disease transmission.

Methods

Available regional pertussis surveillance and vaccination coverage data, supplemented by a literature search for published surveys as well as official national hospital and mortality statistics, were analyzed in the context of respective vaccination recommendations from 1964 onwards.

Results

Routine childhood pertussis vaccination was recommended in the German Democratic Republic (GDR) from 1964 and in former West German states (FWG) from 1969, but withdrawn from 1974–1991 in FWG. Pertussis incidence declined to <1 case/100.000 inhabitants in GDR prior to reunification in 1991, while in FWG, where pertussis was not notifiable after 1961, incidence was estimated at 160–180 cases/100.000 inhabitants in the 1970s-1980s. Despite recommendations for universal childhood immunization in 1991, vaccination coverage decreased in former East German States (FEG) and increased only slowly in FWG. After introduction of acellular pertussis vaccines in 1995, vaccination coverage increased markedly among younger children, but remains low in adolescents, especially in FWG, despite introduction of a booster vaccination for 9–17 year olds in 2000. Reported pertussis incidence increased in FEG to 39.3 cases/100.000 inhabitants in 2007, with the proportion of adults increasing from 20% in 1995 to 68% in 2007. From 2004–2007, incidence was highest among 5–14 year-old children, with a high proportion fully vaccinated according to official recommendations, which did not include a preschool booster until 2006. Hospital discharge statistics revealed a ~2-fold higher pertussis morbidity among infants in FWG than FEG.

Conclusion

The shift in pertussis morbidity to older age groups observed in FEG is similar to reports from other countries with longstanding vaccination programs and suggests that additional booster vaccination may be necessary beyond adolescence. The high proportion of fully vaccinated cases in older children in FEG suggests waning immunity 5–10 years after primary immunisation in infancy. The higher incidence of pertussis hospitalisations in infants suggests a stronger force of infection in FWG than FEG. Nationwide pertussis reporting is required for better evaluation of transmission patterns and vaccination policy in both parts of Germany.
Appendix
Available only for authorised users
Literature
1.
go back to reference Edwards KM: Pertussis epidemiology and transmission 541. Advanced Studies in Medicine. 2005, 5: S440-S443. Edwards KM: Pertussis epidemiology and transmission 541. Advanced Studies in Medicine. 2005, 5: S440-S443.
2.
go back to reference Tan T, Trindade E, Skowronski D: Epidemiology of pertussis. Pediatr Infect Dis J. 2005, 24: S10-S18. 10.1097/01.inf.0000160708.43944.99.CrossRefPubMed Tan T, Trindade E, Skowronski D: Epidemiology of pertussis. Pediatr Infect Dis J. 2005, 24: S10-S18. 10.1097/01.inf.0000160708.43944.99.CrossRefPubMed
3.
go back to reference Celentano LP, Massari M, Paramatti D, Salmaso S, Tozzi AE: Resurgence of Pertussis in Europe. Pediatr Infect Dis J. 2005, 24: 761-765. 10.1097/01.inf.0000177282.53500.77.CrossRefPubMed Celentano LP, Massari M, Paramatti D, Salmaso S, Tozzi AE: Resurgence of Pertussis in Europe. Pediatr Infect Dis J. 2005, 24: 761-765. 10.1097/01.inf.0000177282.53500.77.CrossRefPubMed
4.
go back to reference Grgic-Vitek M, Klavs I, Kraigher A: Re-emergence of pertussis in Slovenia: Time to change immunization policy. Vaccine. 2008, 26: 1874-1878. 10.1016/j.vaccine.2008.01.045.CrossRefPubMed Grgic-Vitek M, Klavs I, Kraigher A: Re-emergence of pertussis in Slovenia: Time to change immunization policy. Vaccine. 2008, 26: 1874-1878. 10.1016/j.vaccine.2008.01.045.CrossRefPubMed
6.
go back to reference Greenberg DP, von Konig CH, Heininger U: Health burden of pertussis in infants and children. Pediatr Infect Dis J. 2005, 24: S39-S43. 10.1097/01.inf.0000160911.65632.e1.CrossRefPubMed Greenberg DP, von Konig CH, Heininger U: Health burden of pertussis in infants and children. Pediatr Infect Dis J. 2005, 24: S39-S43. 10.1097/01.inf.0000160911.65632.e1.CrossRefPubMed
7.
go back to reference Heininger U, Klich K, Stehr K, Cherry JD: Clinical Findings in Bordetella pertussis Infections: Results of a Prospective Multicenter Surveillance Study. Pediatrics. 1997, 100: e10-10.1542/peds.100.6.e10.CrossRefPubMed Heininger U, Klich K, Stehr K, Cherry JD: Clinical Findings in Bordetella pertussis Infections: Results of a Prospective Multicenter Surveillance Study. Pediatrics. 1997, 100: e10-10.1542/peds.100.6.e10.CrossRefPubMed
8.
go back to reference Stojanov S, Liese J, Belohradsky BH: Hospitalization and Complications in Children under 2 Years of Age with Bordetella pertussis Infection. Infection. 2000, V28: 106-110. 10.1007/s150100050056.CrossRef Stojanov S, Liese J, Belohradsky BH: Hospitalization and Complications in Children under 2 Years of Age with Bordetella pertussis Infection. Infection. 2000, V28: 106-110. 10.1007/s150100050056.CrossRef
9.
go back to reference Rothstein E, Edwards K: Health burden of pertussis in adolescents and adults. Pediatr Infect Dis J. 2005, 24: S44-S47. 10.1097/01.inf.0000160912.58660.87.CrossRefPubMed Rothstein E, Edwards K: Health burden of pertussis in adolescents and adults. Pediatr Infect Dis J. 2005, 24: S44-S47. 10.1097/01.inf.0000160912.58660.87.CrossRefPubMed
10.
go back to reference Greenberg DP: Pertussis in adolescents: increasing incidence brings attention to the need for booster immunization of adolescents. Pediatr Infect Dis J. 2005, 24: 721-728. 10.1097/01.inf.0000172905.08606.a3.CrossRefPubMed Greenberg DP: Pertussis in adolescents: increasing incidence brings attention to the need for booster immunization of adolescents. Pediatr Infect Dis J. 2005, 24: 721-728. 10.1097/01.inf.0000172905.08606.a3.CrossRefPubMed
11.
go back to reference Postels-Multani S, Wirsing von Koenig CH, Schmitt HJ, Bock HL, Bogaerts H: Symptoms and complications of pertussis in adults. Infection. 1995, V23: 139-142. 10.1007/BF01793853.CrossRef Postels-Multani S, Wirsing von Koenig CH, Schmitt HJ, Bock HL, Bogaerts H: Symptoms and complications of pertussis in adults. Infection. 1995, V23: 139-142. 10.1007/BF01793853.CrossRef
12.
go back to reference DeSerres G, Shadmani R, Duval B, Boulianne N, Dery P, DouvilleFradet M, Rochette L, Halperin S: Morbidity of Pertussis in Adolescents and Adults. The Journal of Infectious Diseases. 2000, 182: 174-179. 10.1086/315648.CrossRef DeSerres G, Shadmani R, Duval B, Boulianne N, Dery P, DouvilleFradet M, Rochette L, Halperin S: Morbidity of Pertussis in Adolescents and Adults. The Journal of Infectious Diseases. 2000, 182: 174-179. 10.1086/315648.CrossRef
13.
go back to reference Edwards KM: Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr Infect Dis J. 2005, 24: S104-S108. 10.1097/01.inf.0000166154.47013.47.CrossRefPubMed Edwards KM: Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr Infect Dis J. 2005, 24: S104-S108. 10.1097/01.inf.0000166154.47013.47.CrossRefPubMed
14.
go back to reference Wendelboe AM, Van RA, Salmaso S, Englund JA: Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J. 2005, 24: S58-S61. 10.1097/01.inf.0000160914.59160.41.CrossRefPubMed Wendelboe AM, Van RA, Salmaso S, Englund JA: Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J. 2005, 24: S58-S61. 10.1097/01.inf.0000160914.59160.41.CrossRefPubMed
15.
go back to reference Anderson RM, May RM: Immunisation and herd immunity. Lancet. 1990, 335: 641-645. 10.1016/0140-6736(90)90420-A.CrossRefPubMed Anderson RM, May RM: Immunisation and herd immunity. Lancet. 1990, 335: 641-645. 10.1016/0140-6736(90)90420-A.CrossRefPubMed
16.
go back to reference Koch MA, Dittmann S: Impfempfehlungen in Deutschland. Entwicklung der STIKO-Empfehlungen und der Impfempfehlungen in der DDR. Kinderärztliche Praxis. 1999, 6: 350-364. Koch MA, Dittmann S: Impfempfehlungen in Deutschland. Entwicklung der STIKO-Empfehlungen und der Impfempfehlungen in der DDR. Kinderärztliche Praxis. 1999, 6: 350-364.
17.
go back to reference Pöhn HP, Rasch G: Statistik meldepflichtiger Übertragbarer Krankheiten. 1993, München: Medizin Verlag München Pöhn HP, Rasch G: Statistik meldepflichtiger Übertragbarer Krankheiten. 1993, München: Medizin Verlag München
18.
go back to reference Robert Koch-Institut: Falldefinitionen für meldepflichtige Infektionskrankheiten. Epidemiol Bull. 2002, 2: 9-13. Robert Koch-Institut: Falldefinitionen für meldepflichtige Infektionskrankheiten. Epidemiol Bull. 2002, 2: 9-13.
19.
go back to reference Abu Sin M, Zenke R, Rönckendorf R, Littmann M, Jorgensen P, Hellenbrand W: Pertussis outbreak in primary and secondary schools in Ludwigslust, Germany – the role of waning immunity. Pediatr Infect Dis J. 2008, Abu Sin M, Zenke R, Rönckendorf R, Littmann M, Jorgensen P, Hellenbrand W: Pertussis outbreak in primary and secondary schools in Ludwigslust, Germany – the role of waning immunity. Pediatr Infect Dis J. 2008,
20.
go back to reference Dittmann S, Thilo W: Vademekum für Impfärzte. 1986, Jena: VEB Gustav Fischer Verlag Dittmann S, Thilo W: Vademekum für Impfärzte. 1986, Jena: VEB Gustav Fischer Verlag
21.
go back to reference Ministerium für Gesundheitswesen der DDR: Anordnung über die Termine für die Durchführung von Schutzimpfungen – Impfkalender – vom 9. September 1971. Gesetzblatt der Deutschen Demokratischen Republik II, Nr. 70. 1971, 607- Ministerium für Gesundheitswesen der DDR: Anordnung über die Termine für die Durchführung von Schutzimpfungen – Impfkalender – vom 9. September 1971. Gesetzblatt der Deutschen Demokratischen Republik II, Nr. 70. 1971, 607-
22.
go back to reference Ministerium für Gesundheitswesen der DDR: Anordnung über die Termine für die Durchführung von Schutzimpfungen – Impfkalender – vom 23. Juli 1974. Gesetzblatt der Deutschen Demokratischen Republik I, Nr. 39. 1974, 371- Ministerium für Gesundheitswesen der DDR: Anordnung über die Termine für die Durchführung von Schutzimpfungen – Impfkalender – vom 23. Juli 1974. Gesetzblatt der Deutschen Demokratischen Republik I, Nr. 39. 1974, 371-
23.
go back to reference Ständige Impfkommission am Bundesgesundheitsamt: Arbeitsergebnisse der Ständigen Impfkommission des Bundesgesundheitsamtes. Bundesgesundheitsblatt. 1975, 18: 157- Ständige Impfkommission am Bundesgesundheitsamt: Arbeitsergebnisse der Ständigen Impfkommission des Bundesgesundheitsamtes. Bundesgesundheitsblatt. 1975, 18: 157-
24.
go back to reference Finger H, Wirsing von König CH: Epidemiologie des Keuchhustens. Gesundheitswesen. 1992, 54: 541-545.PubMed Finger H, Wirsing von König CH: Epidemiologie des Keuchhustens. Gesundheitswesen. 1992, 54: 541-545.PubMed
25.
go back to reference Schneeweiß B, Swidinski S: Probleme des Keuchhustens noch nicht gelöst. Epidemiologie und Impfstrategie in Deutschland – landesweite Feldstudie. Fortschritte der Medizin. 1997, 115: 28-30.PubMed Schneeweiß B, Swidinski S: Probleme des Keuchhustens noch nicht gelöst. Epidemiologie und Impfstrategie in Deutschland – landesweite Feldstudie. Fortschritte der Medizin. 1997, 115: 28-30.PubMed
26.
go back to reference Thilo W: Impfen in Deutschland: Erfahrungen aus den neuen Bundesländern. Die Gelben Hefte. 1991, XXXI: 1-7. Thilo W: Impfen in Deutschland: Erfahrungen aus den neuen Bundesländern. Die Gelben Hefte. 1991, XXXI: 1-7.
27.
go back to reference Wirsing von König CH, Schmitt HJ: Epidemiologic aspects and diagnostic criteria for a protective efficacy field trial of a pertussis vaccine. The Journal of Infectious Diseases. 1996, 174 (Suppl 3): S281-S286.CrossRefPubMed Wirsing von König CH, Schmitt HJ: Epidemiologic aspects and diagnostic criteria for a protective efficacy field trial of a pertussis vaccine. The Journal of Infectious Diseases. 1996, 174 (Suppl 3): S281-S286.CrossRefPubMed
28.
go back to reference Schmitz M, Wassilak SGF, Schulte-Wissermann H, Wirsing von König CH: Schätzung zur Pertussisinzidenz am linken Niederrhein. Monatschrift Kinderheilkunde. 1994, 142: 41-44. Schmitz M, Wassilak SGF, Schulte-Wissermann H, Wirsing von König CH: Schätzung zur Pertussisinzidenz am linken Niederrhein. Monatschrift Kinderheilkunde. 1994, 142: 41-44.
29.
go back to reference Ständige Impfkommission am Bundesgesundheitsamt: Impfempfehlungen der Ständigen Impfkommssion des Bundesgesundheitsamtes (STIKO) – Stand: Juli 1991. Bundesgesundheitsblatt. 1991, 8: 384-388. Ständige Impfkommission am Bundesgesundheitsamt: Impfempfehlungen der Ständigen Impfkommssion des Bundesgesundheitsamtes (STIKO) – Stand: Juli 1991. Bundesgesundheitsblatt. 1991, 8: 384-388.
30.
go back to reference Ständige Impfkommission am Bundesgesundheitsamt: Impfempfehlungen der Ständigen Impfkommisssion des Bundesgesundheitsamtes (STIKO) – Stand: September 1993. Bundesgesundheitsblatt. 1994, 37: 85-91. Ständige Impfkommission am Bundesgesundheitsamt: Impfempfehlungen der Ständigen Impfkommisssion des Bundesgesundheitsamtes (STIKO) – Stand: September 1993. Bundesgesundheitsblatt. 1994, 37: 85-91.
31.
go back to reference STIKO: Mitteilung der Ständigen Impfkommission am Robert Koch-Institut: Impfempfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand: Januar 2000. Epidemiol Bull. 2000, 9-20. STIKO: Mitteilung der Ständigen Impfkommission am Robert Koch-Institut: Impfempfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand: Januar 2000. Epidemiol Bull. 2000, 9-20.
32.
go back to reference STIKO: Mitteilung der Ständigen Impfkommission am Robert Koch-Institut: Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand: Juli 2003. Epidemiol Bull. 2003, 245-260. STIKO: Mitteilung der Ständigen Impfkommission am Robert Koch-Institut: Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand: Juli 2003. Epidemiol Bull. 2003, 245-260.
33.
go back to reference STIKO: Mitteilung der Ständigen Impfkommission am Robert Koch-Institut: Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand: Juli 2004. Epidemiol Bull. 2004, 235-250. STIKO: Mitteilung der Ständigen Impfkommission am Robert Koch-Institut: Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand: Juli 2004. Epidemiol Bull. 2004, 235-250.
34.
go back to reference Sächsische Impfkommission (SIKO): Empfehlungen der Sächsischen Impfkommission. LUA Mitteilung. 2007, 1: 12-16. Sächsische Impfkommission (SIKO): Empfehlungen der Sächsischen Impfkommission. LUA Mitteilung. 2007, 1: 12-16.
35.
go back to reference Kirschner W, Koch J: Durchimpfungsgrade und Impfverhalten bei Kindern in West- und Ostdeutschland im Jahr 1994. Infektionsepidemiologische Forschung. 1995, 4: 10-16. Kirschner W, Koch J: Durchimpfungsgrade und Impfverhalten bei Kindern in West- und Ostdeutschland im Jahr 1994. Infektionsepidemiologische Forschung. 1995, 4: 10-16.
36.
go back to reference Poethko-Müller C, Kuhnert T, Schlaud M: Durchimpfung und Determinanten des Impfstatus in Deutschland. Ergebnisse des Kinder- und Jugendgesundheitssurveys (KiGGS). Bundesgesundheitsbl – Gesundheitsforsch – Gesundheitsschutz. 2007, 50: 851-862. 10.1007/s00103-007-0248-0.CrossRef Poethko-Müller C, Kuhnert T, Schlaud M: Durchimpfung und Determinanten des Impfstatus in Deutschland. Ergebnisse des Kinder- und Jugendgesundheitssurveys (KiGGS). Bundesgesundheitsbl – Gesundheitsforsch – Gesundheitsschutz. 2007, 50: 851-862. 10.1007/s00103-007-0248-0.CrossRef
37.
go back to reference Robert Koch-Institut: Pertussis: Zum vergleich von Grundimmuniserung und Auffrischimpfungen in den alten und neuen Bundesländern: Daten aus dem Kinder und Jugendgesundheitssurvey (KiGGS). Epidemiol Bull. 2008, 27: 213-214. Robert Koch-Institut: Pertussis: Zum vergleich von Grundimmuniserung und Auffrischimpfungen in den alten und neuen Bundesländern: Daten aus dem Kinder und Jugendgesundheitssurvey (KiGGS). Epidemiol Bull. 2008, 27: 213-214.
38.
go back to reference Robert Koch-Institut: Impfempfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand: Januar 2000. Epidemiol Bull. 2000, 2: 9-20. Robert Koch-Institut: Impfempfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand: Januar 2000. Epidemiol Bull. 2000, 2: 9-20.
40.
go back to reference Riffelmann M, Littmann M, Hülße C, O'Brien J, Wirsing von Konig CH, KRESH-Studienärzte: Pertussis bei Erwachsenen: Häufigkeit, Symptome und Kosten. Dtsch Med Wochenschr. 2006, 131: 2829-2834. 10.1055/s-2006-957208.CrossRefPubMed Riffelmann M, Littmann M, Hülße C, O'Brien J, Wirsing von Konig CH, KRESH-Studienärzte: Pertussis bei Erwachsenen: Häufigkeit, Symptome und Kosten. Dtsch Med Wochenschr. 2006, 131: 2829-2834. 10.1055/s-2006-957208.CrossRefPubMed
41.
go back to reference Gangarosa EJ, Galazka AM, Wolfe CR, Phillips LM, Gangarosa RE, MILLER E, Chen RT: Impact of anti-vaccine movements on pertussis control: the untold story. Lancet. 1998, 351: 356-361. 10.1016/S0140-6736(97)04334-1.CrossRefPubMed Gangarosa EJ, Galazka AM, Wolfe CR, Phillips LM, Gangarosa RE, MILLER E, Chen RT: Impact of anti-vaccine movements on pertussis control: the untold story. Lancet. 1998, 351: 356-361. 10.1016/S0140-6736(97)04334-1.CrossRefPubMed
42.
go back to reference Kosters K, Riffelmann M, Dohrn B, von Konig CHW: Comparison of Five Commercial Enzyme-Linked Immunosorbent Assays for Detection of Antibodies to Bordetella pertussis. Clin Diagn Lab Immunol. 2000, 7: 422-426. 10.1128/CDLI.7.3.422-426.2000.PubMedPubMedCentral Kosters K, Riffelmann M, Dohrn B, von Konig CHW: Comparison of Five Commercial Enzyme-Linked Immunosorbent Assays for Detection of Antibodies to Bordetella pertussis. Clin Diagn Lab Immunol. 2000, 7: 422-426. 10.1128/CDLI.7.3.422-426.2000.PubMedPubMedCentral
43.
go back to reference Watanabe M, Nagai M: Acellular pertussis vaccines in Japan: past, present and future. Expert Rev Vaccines. 2005, 4: 173-184. 10.1586/14760584.4.2.173.CrossRefPubMed Watanabe M, Nagai M: Acellular pertussis vaccines in Japan: past, present and future. Expert Rev Vaccines. 2005, 4: 173-184. 10.1586/14760584.4.2.173.CrossRefPubMed
44.
go back to reference Wirsing von König CH, Gounis D, Schmitt HJ, Laukamp W, Bogaerts H: Evaluation of a Single-Sample Serological Technique for Diagnosing Pertussis in Unvaccinated Children. European Journal of Clinical Microbiology and Infectious Diseases. 1999, 18: 341-345. 10.1007/PL00015016.CrossRefPubMed Wirsing von König CH, Gounis D, Schmitt HJ, Laukamp W, Bogaerts H: Evaluation of a Single-Sample Serological Technique for Diagnosing Pertussis in Unvaccinated Children. European Journal of Clinical Microbiology and Infectious Diseases. 1999, 18: 341-345. 10.1007/PL00015016.CrossRefPubMed
45.
go back to reference Nardone A, Pebody RG, Maple PAC, Andrews N, Gay NJ, MILLER E: Sero-epidemiology of Bordetella pertussis in England and Wales. Vaccine. 2004, 22: 1314-1319. 10.1016/j.vaccine.2003.08.039.CrossRefPubMed Nardone A, Pebody RG, Maple PAC, Andrews N, Gay NJ, MILLER E: Sero-epidemiology of Bordetella pertussis in England and Wales. Vaccine. 2004, 22: 1314-1319. 10.1016/j.vaccine.2003.08.039.CrossRefPubMed
46.
go back to reference Wirsing von König CH, Postels-Multani S, Bogaerts H, Bock HL, Laukamp S, Kiederle S, Schmitt HJ: Factors influencing the spread of pertussis in households. European Journal of Pediatrics. 1998, 157: 391-394. 10.1007/s004310050836.CrossRefPubMed Wirsing von König CH, Postels-Multani S, Bogaerts H, Bock HL, Laukamp S, Kiederle S, Schmitt HJ: Factors influencing the spread of pertussis in households. European Journal of Pediatrics. 1998, 157: 391-394. 10.1007/s004310050836.CrossRefPubMed
47.
go back to reference Tan T: Summary: epidemiology of pertussis. Pediatr Infect Dis J. 2005, 24: S35-S38. 10.1097/01.inf.0000160910.17950.59.CrossRefPubMed Tan T: Summary: epidemiology of pertussis. Pediatr Infect Dis J. 2005, 24: S35-S38. 10.1097/01.inf.0000160910.17950.59.CrossRefPubMed
48.
go back to reference CDC: Pertussis – United States, 2001–2003. MMWR Morb Mortal Wkly Rep. 2005, 54 (50): 1283-1286. CDC: Pertussis – United States, 2001–2003. MMWR Morb Mortal Wkly Rep. 2005, 54 (50): 1283-1286.
49.
go back to reference Guris D, Strebel PM, Bardenheier B, Brennan M, Tachdjian R, Finch E, Wharton M, Livengood JR: Changing Epidemiology of Pertussis in the United States: Increasing Reported Incidence Among Adolescents and Adults, 1990–1996. Clin Infect Dis. 1999, 28: 1230-1237. 10.1086/514776.CrossRefPubMed Guris D, Strebel PM, Bardenheier B, Brennan M, Tachdjian R, Finch E, Wharton M, Livengood JR: Changing Epidemiology of Pertussis in the United States: Increasing Reported Incidence Among Adolescents and Adults, 1990–1996. Clin Infect Dis. 1999, 28: 1230-1237. 10.1086/514776.CrossRefPubMed
50.
go back to reference Aguas R, Goncalves G, Gomes MG: Pertussis: increasing disease as a consequence of reducing transmission. The Lancet Infectious Diseases. 2006, 6: 112-117. 10.1016/S1473-3099(06)70384-X.CrossRefPubMed Aguas R, Goncalves G, Gomes MG: Pertussis: increasing disease as a consequence of reducing transmission. The Lancet Infectious Diseases. 2006, 6: 112-117. 10.1016/S1473-3099(06)70384-X.CrossRefPubMed
51.
go back to reference Dittmann S, Müller H: Vademekum für Impfärzte. 1977, Jena: VEB Gustav Fischer Verlag Dittmann S, Müller H: Vademekum für Impfärzte. 1977, Jena: VEB Gustav Fischer Verlag
52.
go back to reference Pittman M: History of the development of pertussis vaccine. Developments in Biological Standardization. 1991, 73: 13-29.PubMed Pittman M: History of the development of pertussis vaccine. Developments in Biological Standardization. 1991, 73: 13-29.PubMed
53.
go back to reference Wendelboe AM, Van RA, Salmaso S, Englund JA: Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J. 2005, 24: S58-S61. 10.1097/01.inf.0000160914.59160.41.CrossRefPubMed Wendelboe AM, Van RA, Salmaso S, Englund JA: Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J. 2005, 24: S58-S61. 10.1097/01.inf.0000160914.59160.41.CrossRefPubMed
54.
go back to reference Bisgard KM, Pascual FB, Ehresmann KR, Miller CA, Cianfrini C, Jennings CE, Rebmann CA, Gabel JG, Schauer SL, Lett SM: Infant Pertussis. Who was the source?. Pediatr Infect Dis J. 2004, 23: 985-989. 10.1097/01.inf.0000145263.37198.2b.CrossRefPubMed Bisgard KM, Pascual FB, Ehresmann KR, Miller CA, Cianfrini C, Jennings CE, Rebmann CA, Gabel JG, Schauer SL, Lett SM: Infant Pertussis. Who was the source?. Pediatr Infect Dis J. 2004, 23: 985-989. 10.1097/01.inf.0000145263.37198.2b.CrossRefPubMed
55.
go back to reference Bonmarin I, Levy-Bruhl D, Baron S, Guiso N, Njamkepo E, Caro V, Renacoq participants: Pertussis surveillance in French hospitals: results from a 10 year period. Euro Surveill. 2007, 12 (1): Bonmarin I, Levy-Bruhl D, Baron S, Guiso N, Njamkepo E, Caro V, Renacoq participants: Pertussis surveillance in French hospitals: results from a 10 year period. Euro Surveill. 2007, 12 (1):
56.
go back to reference Crowcroft NS, Booy R, Harrison T, Spicer L, Britto J, Mok Q, Heath P, Murdoch I, Zambon M, George R, et al: Severe and unrecognised: pertussis in UK infants. Arch Dis Child. 2003, 88: 802-806. 10.1136/adc.88.9.802.CrossRefPubMedPubMedCentral Crowcroft NS, Booy R, Harrison T, Spicer L, Britto J, Mok Q, Heath P, Murdoch I, Zambon M, George R, et al: Severe and unrecognised: pertussis in UK infants. Arch Dis Child. 2003, 88: 802-806. 10.1136/adc.88.9.802.CrossRefPubMedPubMedCentral
57.
go back to reference Kowalzik FM, Barbosa APMP+, Fernandes VRM, Carvalho PRP, Avila-Aguero MLM, Goh DYTF, Goh AM, de Miguel MJGM, Moraga FM, Roca JM, et al: Prospective Multinational Study of Pertussis Infection in Hospitalized Infants and Their Household Contacts. [Article]. Pediatr Infect Dis J. 2007, 26: 238-242. 10.1097/01.inf.0000256750.07118.ee.CrossRefPubMed Kowalzik FM, Barbosa APMP+, Fernandes VRM, Carvalho PRP, Avila-Aguero MLM, Goh DYTF, Goh AM, de Miguel MJGM, Moraga FM, Roca JM, et al: Prospective Multinational Study of Pertussis Infection in Hospitalized Infants and Their Household Contacts. [Article]. Pediatr Infect Dis J. 2007, 26: 238-242. 10.1097/01.inf.0000256750.07118.ee.CrossRefPubMed
58.
go back to reference Wendelboe AMP, Njamkepo EP, Bourillon AM, Floret DDM, Gaudelus JM, Gerber MM, Grimprel EM, Greenberg DM, Halperin SM, Liese JM, et al: Transmission of Bordetella pertussis to Young Infants. [Article]. Pediatr Infect Dis J. 2007, 26: 293-299. 10.1097/01.inf.0000258699.64164.6d.CrossRefPubMed Wendelboe AMP, Njamkepo EP, Bourillon AM, Floret DDM, Gaudelus JM, Gerber MM, Grimprel EM, Greenberg DM, Halperin SM, Liese JM, et al: Transmission of Bordetella pertussis to Young Infants. [Article]. Pediatr Infect Dis J. 2007, 26: 293-299. 10.1097/01.inf.0000258699.64164.6d.CrossRefPubMed
59.
go back to reference Juretzko P, Fabian-Marx T, Haasert B, Giant G, v.Kries R, Wirsing von Konig CH: Pertussis in Germany: regional differences in management and vaccination status of hospitalized cases. Epidemiology and Infection. 2001, 127: 63-71. 10.1017/S0950268801005593.CrossRefPubMedPubMedCentral Juretzko P, Fabian-Marx T, Haasert B, Giant G, v.Kries R, Wirsing von Konig CH: Pertussis in Germany: regional differences in management and vaccination status of hospitalized cases. Epidemiology and Infection. 2001, 127: 63-71. 10.1017/S0950268801005593.CrossRefPubMedPubMedCentral
60.
go back to reference Weber I: Alte und neue Bundesländer: Mehr Patienten, weniger Ärzte und geringere Finanzmittel. Dtsch Arztebl. 2005, 4: 540- Weber I: Alte und neue Bundesländer: Mehr Patienten, weniger Ärzte und geringere Finanzmittel. Dtsch Arztebl. 2005, 4: 540-
61.
go back to reference Pebody RG, Gay NJ, Giammanco A, Baron S, Schellekens J, Tischer A, Olander RM, Andrews NJ, Edmunds WJ, Lecoeur H, et al: The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect. 2005, 133: 159-171. 10.1017/S0950268804003012.CrossRefPubMedPubMedCentral Pebody RG, Gay NJ, Giammanco A, Baron S, Schellekens J, Tischer A, Olander RM, Andrews NJ, Edmunds WJ, Lecoeur H, et al: The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect. 2005, 133: 159-171. 10.1017/S0950268804003012.CrossRefPubMedPubMedCentral
62.
go back to reference Giammanco A, Chiarini A, Maple PAC, Andrews N, Pebody R, Gay N, Ölander RM, Fivet-Groyne F, Baron S, Tischer A, et al: European Sero-Epidemiology Network: standardisation of the assay results for pertussis. Vaccine. 2003, 22: 112-120. 10.1016/S0264-410X(03)00514-0.CrossRefPubMed Giammanco A, Chiarini A, Maple PAC, Andrews N, Pebody R, Gay N, Ölander RM, Fivet-Groyne F, Baron S, Tischer A, et al: European Sero-Epidemiology Network: standardisation of the assay results for pertussis. Vaccine. 2003, 22: 112-120. 10.1016/S0264-410X(03)00514-0.CrossRefPubMed
63.
go back to reference Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, Tomba GS, Wallinga J, et al: Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases. PLoS Medicine. 2008, 5: e74-10.1371/journal.pmed.0050074.CrossRefPubMedPubMedCentral Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, Tomba GS, Wallinga J, et al: Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases. PLoS Medicine. 2008, 5: e74-10.1371/journal.pmed.0050074.CrossRefPubMedPubMedCentral
64.
go back to reference Federal Statistical Office: Statistisches Jahrbuch 2007. 2008, Wiesbaden: Federal Statistical Office Federal Statistical Office: Statistisches Jahrbuch 2007. 2008, Wiesbaden: Federal Statistical Office
65.
go back to reference Forsyth KD, Wirsing von Konig C-H, Tan T, Caro J, Plotkin S: Prevention of pertussis: Recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine. 2007, 25: 2634-2642. 10.1016/j.vaccine.2006.12.017.CrossRefPubMed Forsyth KD, Wirsing von Konig C-H, Tan T, Caro J, Plotkin S: Prevention of pertussis: Recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine. 2007, 25: 2634-2642. 10.1016/j.vaccine.2006.12.017.CrossRefPubMed
Metadata
Title
The epidemiology of pertussis in Germany: past and present
Authors
Wiebke Hellenbrand
Dietmar Beier
Evelin Jensen
Martina Littmann
Christiane Meyer
Hanna Oppermann
Carl-Heinz Wirsing von König
Sabine Reiter
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2009
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-9-22

Other articles of this Issue 1/2009

BMC Infectious Diseases 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.